These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6171084)

  • 21. Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
    Montironi R; Magi-Galluzzi C; Muzzonigro G; Prete E; Polito M; Fabris G
    J Clin Pathol; 1994 Oct; 47(10):906-13. PubMed ID: 7525657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratin immunoreactivity in the benign and neoplastic human prostate.
    Brawer MK; Peehl DM; Stamey TA; Bostwick DG
    Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective osteoblast mitogens can be extracted from prostatic tissue.
    Koutsilieris M; Rabbani SA; Goltzman D
    Prostate; 1986; 9(2):109-15. PubMed ID: 2428019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer.
    Zhang L; Zhou J; Fan S; Liang CZ
    Asian J Androl; 2016; 18(4):654-6. PubMed ID: 26208396
    [No Abstract]   [Full Text] [Related]  

  • 25. Lactoferrin demonstration in thyroid follicular and papillary carcinomas.
    Barresi G; Tuccari G
    Arch Pathol Lab Med; 1988 Dec; 112(12):1176-7. PubMed ID: 3190398
    [No Abstract]   [Full Text] [Related]  

  • 26. Localization of lactoferrin in the male reproductive tract.
    Wichmann L; Vaalasti A; Vaalasti T; Tuohimaa P
    Int J Androl; 1989 Jun; 12(3):179-86. PubMed ID: 2767778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid receptors in human prostatic cancer a preliminary evaluation.
    de Voogt HJ; Dingjan P
    Urol Res; 1978; 6(3):151-8. PubMed ID: 81556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma.
    Mydlo JH; Michaeli J; Heston WD; Fair WR
    Prostate; 1988; 13(3):241-7. PubMed ID: 2463616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transition zone volume measurement--is it useful before surgery for benign prostatic hyperplasia?
    Milonas D; Matjosaitis A; Jievaltas M
    Medicina (Kaunas); 2007; 43(10):792-7. PubMed ID: 17998796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue.
    Korkes F; de Castro MG; de Cassio Zequi S; Nardi L; Del Giglio A; de Lima Pompeo AC
    BJU Int; 2014 May; 113(5):822-9. PubMed ID: 24053431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.
    Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA
    Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
    Daver A; Soret JY; Coblentz Y; Allain YM; Cellier P; Chauveau P
    Am J Clin Oncol; 1988; 11 Suppl 2():S53-60. PubMed ID: 2468273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
    Shida K
    Horumon To Rinsho; 1980 Aug; 28(8):899-928. PubMed ID: 6161722
    [No Abstract]   [Full Text] [Related]  

  • 36. Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6.
    Abrahams NA; Bostwick DG; Ormsby AH; Qian J; Brainard JA
    Am J Clin Pathol; 2003 Sep; 120(3):368-76. PubMed ID: 14502799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endogenous androgen levels of human prostatic tissues].
    Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
    Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single case report of prostate adenocarcinoma in a dog castrated three months previously. Morphological, biochemical, and endocrine determinations.
    Dubé JY; Frenette G; Tremblay Y; Bélanger A; Tremblay RR
    Prostate; 1984; 5(5):495-501. PubMed ID: 6207517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nuclear content of deoxyribonucleic acid in the epithelium of hypertrophic prostate and prostatic carcinoma].
    Yamauchi A
    Nihon Hinyokika Gakkai Zasshi; 1970 Dec; 61(12):1170-83. PubMed ID: 4099311
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogen receptors and clinical correlations with human prostatic disease.
    Pontes JE; Karr JP; Kirdani RY; Murphy GP; Sandberg AA
    Urology; 1982 Apr; 19(4):399-403. PubMed ID: 6176061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.